GET Stock QuotesNews18 APP
News18 English
»
1-min read

Zydus Cadila Gets USFDA Nod For Migraine Drug

Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.

IANS

Updated:June 19, 2017, 6:33 PM IST
facebookTwittergoogleskypewhatsapp
Zydus Cadila Gets USFDA Nod For Migraine Drug
Zydus Cadila will sell Eletriptan Hydrobromide tablets used in the treatment of migraine. (Photo courtesy: zyduscadila.com)
Loading...
Mumbai: Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.

According to the company, the drug with strengths 20mg and 40mg will be produced at the group's formulations manufacturing facility at the Pharma SEZ (special economic zone) in Ahmedabad.

"The group now has more than 120 approvals and has so far filed over 300 ANDAs (abbreviated new drug applications ) since the commencement of the filing process in FY 2003-04," the firm said in a regulatory filing with the BSE.
Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwittergoogleskypewhatsapp

Live TV

Loading...
Loading...